Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 3
1983 1
1985 1
1986 2
1987 1
1988 1
1989 1
1990 3
1991 5
1992 1
1993 2
1994 1
1995 5
1996 2
1997 2
1998 1
1999 1
2000 3
2001 2
2002 2
2003 1
2008 1
2010 1
2011 2
2012 1
2013 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Remarkable developments in our performance.
Andersson A, Börjesson JL, Westermark K. Andersson A, et al. Among authors: westermark k. Ups J Med Sci. 2020 Nov;125(4):263-264. doi: 10.1080/03009734.2020.1830579. Epub 2020 Oct 12. Ups J Med Sci. 2020. PMID: 33043754 Free PMC article. No abstract available.
Worldwide collaboration for orphan drug designation.
Mariz S, Reese JH, Westermark K, Greene L, Goto T, Hoshino T, Llinares-Garcia J, Sepodes B. Mariz S, et al. Among authors: westermark k. Nat Rev Drug Discov. 2016 Jun 1;15(6):440-1. doi: 10.1038/nrd.2016.80. Nat Rev Drug Discov. 2016. PMID: 27245396 No abstract available.
European regulation on orphan medicinal products: 10 years of experience and future perspectives.
Committee for Orphan Medicinal Products and the European Medicines; Westermark K, Holm BB, Söderholm M, Llinares-Garcia J, Rivière F, Aarum S, Butlen-Ducuing F, Tsigkos S, Wilk-Kachlicka A, N'Diamoi C, Borvendég J, Lyons D, Sepodes B, Bloechl-Daum B, Lhoir A, Todorova M, Kkolos I, Kubáčková K, Bosch-Traberg H, Tillmann V, Saano V, Héron E, Elbers R, Siouti M, Eggenhofer J, Salmon P, Clementi M, Krieviņš D, Matulevičiene A, Metz H, Vincenti AC, Voordouw A, Dembowska-Bagińska B, Nunes AC, Saleh FM, Foltánová T, Možina M, Torrent i Farnell J, Beerman B, Mariz S, Evers MP, Greene L, Thorsteinsson S, Gramstad L, Mavris M, Bignami F, Lorence A, Belorgey C. Committee for Orphan Medicinal Products and the European Medicines, et al. Among authors: westermark k. Nat Rev Drug Discov. 2011 May;10(5):341-9. doi: 10.1038/nrd3445. Nat Rev Drug Discov. 2011. PMID: 21532564 Review.
Ophthalmopathy and thyroid stimulation.
Karlsson F, Westermark K, Dahlberg PA, Jansson R, Enoksson P. Karlsson F, et al. Among authors: westermark k. Lancet. 1989 Sep 16;2(8664):691. doi: 10.1016/s0140-6736(89)90945-8. Lancet. 1989. PMID: 2570950 No abstract available.
Orphan drugs. EU regulations.
Mariz S, Llinares J, Westermark K. Mariz S, et al. Among authors: westermark k. BMJ. 2011 Jan 11;342:d136. doi: 10.1136/bmj.d136. BMJ. 2011. PMID: 21224321 No abstract available.
Defining orphan conditions in the context of the European orphan regulation: challenges and evolution.
O'Connor DJ, Sheean ME, Hofer MP, Tsigkos S, Mariz S, Fregonese L, Larsson K, Hivert V, Westermark K, Naumann-Winter F, Stoyanova-Beninska V, Barišić I, Capovilla G, Magrelli A, Sepodes B. O'Connor DJ, et al. Among authors: westermark k. Nat Rev Drug Discov. 2019 Jul;18(7):479-480. doi: 10.1038/nrd.2018.128. Nat Rev Drug Discov. 2019. PMID: 30940922 No abstract available.
54 results